Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CONVINCE: Colchicine for Secondary Prevention After Stroke
NCT02898610Phase 3Completed
- Sponsor
- University College Dublin
- Start
- Dec 2016
- Primary completion
- Jan 2024
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 14
01
Overview
A Phase 3 trial of colchicine in ischemic stroke, Transient Ischemic Attack (TIA), sponsored by University College Dublin. Started Dec 2016; status: completed.
02
Drugs
colchicine
03
Conditions
ischemic strokeTransient Ischemic Attack (TIA)
Beyond the preview
Go deeper on NCT02898610.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02898610.